
### [MONDO:0020283](http://purl.obolibrary.org/obo/MONDO_0020283)
**Label:** uveitis (disease)

**Subclasses:** [MONDO:0017259](http://purl.obolibrary.org/obo/MONDO_0017259) (systemic diseases with anterior uveitis), [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0017634](http://purl.obolibrary.org/obo/MONDO_0017634) (non-infectious anterior uveitis), [MONDO:0017255](http://purl.obolibrary.org/obo/MONDO_0017255) (panuveitis (disease)), [MONDO:0017254](http://purl.obolibrary.org/obo/MONDO_0017254) (posterior uveitis (disease)), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0019541](http://purl.obolibrary.org/obo/MONDO_0019541) (non-infectious posterior uveitis), [MONDO:0017261](http://purl.obolibrary.org/obo/MONDO_0017261) (systemic diseases with panuveitis), [MONDO:0017253](http://purl.obolibrary.org/obo/MONDO_0017253) (anterior uveitis), [MONDO:0006806](http://purl.obolibrary.org/obo/MONDO_0006806) (intermediate uveitis (disease)), [MONDO:0017260](http://purl.obolibrary.org/obo/MONDO_0017260) (systemic diseases with posterior uveitis), [MONDO:0006885](http://purl.obolibrary.org/obo/MONDO_0006885) (panuveitis), 

**Corr. equiv. classes:** [Orphanet:280892](http://www.orpha.net/ORDO/Orphanet_280892), [OMIM:MTHU002928](http://purl.obolibrary.org/obo/OMIM_MTHU002928), [OMIM:181000](http://purl.obolibrary.org/obo/OMIM_181000), [OMIM:306400](http://purl.obolibrary.org/obo/OMIM_306400), [Orphanet:85408](http://www.orpha.net/ORDO/Orphanet_85408), [OMIM:138990](http://purl.obolibrary.org/obo/OMIM_138990), [Orphanet:85410](http://www.orpha.net/ORDO/Orphanet_85410), [OMIM:612387](http://purl.obolibrary.org/obo/OMIM_612387), [OMIM:613960](http://purl.obolibrary.org/obo/OMIM_613960), [Orphanet:279914](http://www.orpha.net/ORDO/Orphanet_279914), [OMIM:612388](http://purl.obolibrary.org/obo/OMIM_612388), [Orphanet:306648](http://www.orpha.net/ORDO/Orphanet_306648), [OMIM:233710](http://purl.obolibrary.org/obo/OMIM_233710), [OMIM:233700](http://purl.obolibrary.org/obo/OMIM_233700), [Orphanet:280898](http://www.orpha.net/ORDO/Orphanet_280898), [Orphanet:90061](http://www.orpha.net/ORDO/Orphanet_90061), [Orphanet:280886](http://www.orpha.net/ORDO/Orphanet_280886), [OMIM:233690](http://purl.obolibrary.org/obo/OMIM_233690), [Orphanet:280930](http://www.orpha.net/ORDO/Orphanet_280930), [Orphanet:280933](http://www.orpha.net/ORDO/Orphanet_280933), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797), [Orphanet:379](http://www.orpha.net/ORDO/Orphanet_379), [Orphanet:280926](http://www.orpha.net/ORDO/Orphanet_280926), [OMIM:233670](http://purl.obolibrary.org/obo/OMIM_233670), 

**Class expressions from DL-Learner:**

- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002240](http://purl.obolibrary.org/obo/HP_0002240) (Hepatomegaly) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002088](http://purl.obolibrary.org/obo/HP_0002088) (Abnormality of lung morphology) and [HP:0002240](http://purl.obolibrary.org/obo/HP_0002240) (Hepatomegaly) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 62.50%
- [HP:0001911](http://purl.obolibrary.org/obo/HP_0001911) (Abnormality of granulocytes) and [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0002716](http://purl.obolibrary.org/obo/HP_0002716) (Lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) 62.50%


